local_news
1 min read
Blood Tests Show Elevated PFAS Levels Near Lancashire Chemical Plant
09/25/2026 · New Jersey edition
Why it matters locally: New Jersey has its own history of PFAS contamination, particularly in areas with industrial activity and near military bases, making the findings from Lancashire a relevant concern for state environmental and public health agencies that monitor similar issues.
LANCASHIRE, England – Blood samples collected from individuals residing near a chemical manufacturing facility in Lancashire have shown increased concentrations of per- and polyfluoroalkyl substances, known as PFAS. These chemicals, persistent in the environment and human body, have associations with a range of health conditions. Local authorities initiated the blood testing program in response to community concerns regarding industrial emissions. Participants provided samples for analysis, and researchers subsequently reported the findings to them. Public health officials have communicated with affected residents, providing information about the test results and the implications of PFAS exposure. These communications explain the presence of the chemicals in their systems. Environmental protection agencies have been monitoring the chemical factory's operations and discharge. The factory's activities involve processes that could release PFAS into the surrounding environment. Investigations into the source and extent of the contamination are ongoing. Scientists and medical professionals continue to study the long-term effects of PFAS on human health. Organizations such as the World Health Organization and national health agencies have issued advisories and conducted research on these compounds. Their work informs public health guidance.
Related Topics
Editorial Transparency
AI-Generated · Written by National DeskArticle Ratings
Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0
How do you feel about this story?
NA
National Desk
Trust 3.176467 articles8,284,930 views75% fact accuracy
View ProfileSign in to follow this author from their profile.


Discussion (0)
Join the Conversation
No comments yet. Be the first to comment!